BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NexBio, Inc. 

10665 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-452-2631 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Start Up





 Company News
NexBio, Inc. Anti-Flu Drug Reduces Virus in Trial to Seek New Therapy 9/20/2011 7:47:13 AM    More...
NexBio, Inc.’s DAS181 (Fludase(R)) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis 8/31/2011 6:16:46 AM    More...
NexBio, Inc. Reports Safety and Significant Antiviral Activities of DAS181 (Fludase)* from a Dose-Ranging Phase II Clinical Trial 8/15/2011 10:46:07 AM    More...
Feds Raid San Diego Vaccine Developer NexBio, Inc. 8/5/2011 8:01:46 AM    More...
NexBio, Inc.’s DAS181 (Fludase(R)*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis 2/17/2011 8:30:48 AM    More...
NexBio, Inc. Presents Data at ACAAI 2010 Demonstrating Mechanism of Action for Improvement in Airway Function by DAS181 (Fludase) 11/11/2010 11:51:55 AM    More...
NexBio, Inc. and Weill Cornell Medical College Publish Preclinical Study Showing DAS181 (Fludase(R)*) Anti-Influenza Drug Inhibits Parainfluenza Virus 6/18/2010 9:45:02 AM    More...
NexBio, Inc.: Clinical Trial of DAS181 (Fludase(R)*) in Asthmatics Initiated at the National Institutes of Health (NIH) 5/3/2010 11:05:54 AM    More...
NexBio, Inc. Publishes Preclinical Study Showing DAS181 (Fludase(R)*) Anti-Influenza Therapy Protects Against Secondary Bacterial Pneumonia 3/29/2010 8:47:23 AM    More...
NexBio, Inc. Granted United States Patent Covering DAS181 (Fludase(R) *) and its Use for Prevention and Treatment of Influenza and Parainfluenza 2/9/2010 7:31:40 AM    More...
123